[1] Keijsers R, de Vos Robert-Jan, Kuijer PPF, et al. Tennis elbow[J]. Shoulder Elbow, 2019, 11(5): 384-392.
[2] Pluim BM, Fuller CW, Batt ME, et al.Consensus statement on epidemiological studies of medical conditions in tennis, April 2009[J]. Br J Sports Med, 2009, 43(12): 893-897.
[3] Allander E.Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes[J]. Scand J Rheumatol, 1974, 3(3): 145-153.
[4] Sanders TL Jr, Kremers HM, Bryan AJ, et al.The epidemiology and health care burden of tennis elbow: a population-based study[J]. Am J Sports Med, 2015, 43(5): 1066-1071.
[5] Shiri R, Viikari-Juntura E, Varonen H, et al.Prevalence and determinants of lateral and medial epicondylitis: a population study[J]. Am J Epidemiol, 2006, 164(11): 1065-1074.
[6] Bot SDM, van der Waal JM, Terwee CB, et al. Course and prognosis of elbow complaints: a cohort study in general practice[J]. Ann Rheum Dis, 2005, 64(9): 1331-1336.
[7] Eygendaal D, Rahussen FT, Diercks RL.Biomechanics of the elbow joint in tennis players and relation to pathology[J]. Br J Sports Med, 2007, 41(11): 820-823.
[8] Lee HS, Park HY, Yoon JO, et al.Musicians' medicine: musculoskeletal problems in string players[J]. Clin Orthop Surg, 2013, 5(3): 155-160.
[9] Kraushaar BS, Nirschl RP.Tendinosis of the elbow (tennis elbow), Clinical features and findings of histological, immunohistochemical, and electron microscopy studies[J]. J Bone Joint Surg Am, 1999, 81(2): 259-278.
[10] Vaquero-Picado A, Barco R, Antuna SA.Lateral epicondylitis of the elbow[J]. EFORT Open Rev, 2016, 1(11): 391-397.
[11] Eppley BL, Woodell JE, Higgins J.Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing[J]. PlastReconstr Surg, 2004, 114(6): 1502-1508.
[12] Thanasas C, Papadimitriou G, Charalambidis C, et al.Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial[J]. Am J Sports Med, 2011, 39(10): 2130-214.
[13] Moon YL, Jo SH, Song CH, et al.Autologous bone marrow plasma injection after arthroscopic debridement for elbow tendinosis[J]. Ann Acad Med Singapore, 2008, 37(7): 559-563.
[14] Lee SY, Kim W, Lim C, et al.Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study[J]. Stem Cells, 2015, 33(10): 2995-3005.
[15] Singh A, Gangwar DS, Singh S, Bone marrow injection: A novel treatment for tennis elbow[J]. J Nat Sci Biol Med, 2014, 5(2): 389-391.
[16] Wang A, Breidahl W, Mackie KE, et al.Autologous tenocyte injection for the treatment of severe, chronic resistant lateral epicondylitis: a pilot study[J]. Am J Sports Med, 2013, 41(12): 2925-2932.
[17] Wang A, Mackie K, Breidahl W, et al.Evidence for the Durability of Autologous Tenocyte Injection for Treatment of Chronic Resistant Lateral Epicondylitis: Mean 4.5-Year Clinical Follow-up[J]. Am J Sports Med, 2015, 43(7): 1775-1783.
[18] de la Portilla F, Alba F, García-Olmo D, et al. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial[J]. Int J Colorectal Dis, 2013, 28(3): 313-323.
[19] Ricco S, Renzi S, Del Bue M, et al.Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse[J]. Int J Immunopathol Pharmacol, 2013, 26(1 Suppl): 61-68.
[20] Nixon AJ, Dahlgren LA, Haupt JL, et al.Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis[J]. Am J Vet Res, 2008, 69(7): 928-937.
[21] Betsch M, Thelen S, Santak L, et al.The role of erythropoietin and bone marrow concentrate in the treatment of osteochondral defects in mini-pigs[J]. PLoS One, 2014, 9(3): e92766.
[22] Chu CR, Fortier LA, Williams A, et al.Minimally Manipulated Bone Marrow Concentrate Compared with Microfracture Treatment of Full-Thickness Chondral Defects: A One-Year Study in an Equine Model[J]. J Bone Joint Surg Am, 2018, 100(2): 138-146.
[23] Gugjoo MB, Amarpal, Abdelbaset-Ismail A, et al. Mesenchymal stem cells with IGF-1 and TGF- β in laminin gel for osteochondral defects in rabbits[J]. Biomed Pharmacother, 2017, 93: 1165-1174.
[24] Mahmoud EE, Adachi N, Mawas AS, et al.Coculturing of mesenchymal stem cells of different sources improved regenerative capability of osteochondral defect in the mature rabbit: An in vivo study[J]. J Orthop Surg(Hong Kong), 2019, 27(2): 2309499019839850.
[25] Veronesi F, Desando G, Fini M, et al.Bone marrow concentrate and expanded mesenchymal stromal cell surnatants as cell-free approaches for the treatment of osteochondral defects in a preclinical animal model[J]. Int Orthop, 2019, 43(1): 25-34.
[26] Murphy EP, McGoldrick NP, Curtin M, et al. A prospective evaluation of bone marrow aspirate concentrate and microfracture in the treatment of osteochondral lesions of the talus[J]. Foot Ankle Surg, 2019, 25(4): 441-448.
[27] Tarpada SP, Morris MT, Lian J, et al.Current advances in the treatment of medial and lateral epicondylitis[J]. J Orthop, 2018, 15(1): 107-110.
[28] Zhang S, Chu WC, Lai RC, et al.Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration[J]. Osteoarthritis Cartilage, 2016, 24(12): 2135-2140.
[29] Ohtera K, Yamada Y, Aoki M, et al.Effects of periosteum wrapped around tendon in a bone tunnel: A biomechanical and histological study in rabbits[J]. Crit Rev Biomed Eng, 2000, 28(1-2): 115-118.
[30] Lui PP, Chan KM.Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications[J]. Stem Cell Rev Rep, 2011, 7(4): 883-897.
[31] Chen J, Yu Q, Wu B, et al.Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit model[J]. Tissue Eng Part A, 2011, 17(15-16): 2037-2048.
[32] Chen JM, Willers C, Xu J, et al.Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits[J]. Tissue Eng, 2007, 13(7): 1479-1491.
[33] Klopp AH, Gupta A, Spaeth E, et al.Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?[J]. Stem Cells, 2011, 29(1): 11-19.
[34] Peister A, Mellad JA, Larson BL, et al.Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential[J]. Blood, 2004, 103(5): 1662-1668.
[35] Bain BJ.Bone marrow biopsy morbidity: review of 2003[J]. J Clin Pathol, 2005, 58(4): 406-408.
[36] Burkle CM, Harrison BA, Koenig LF, et al.Morbidity and mortality of deep sedation in outpatient bone marrow biopsy[J]. Am J Hematol, 2004, 77(3): 250-256. |
